Recombinant TCR ligand reverses clinical signs and CNS damage of EAE induced by recombinant human MOG

Lignende værker

• RTL551 treatment of EAE reduces CD226 and T-bet+ CD4 T cells in periphery and prevents infiltration of T-bet+ IL-17, IFN-γ producing T cells into CNS.
  af: Sushmita Sinha, et al.
  Udgivet: (2011-01-01)
• RTL551 Treatment of EAE Reduces CD226 and T-bet+ CD4 T Cells in Periphery and Prevents Infiltration of T-bet+ IL-17, IFN-γ Producing T Cells into CNS
  af: Sinha, Sushmita, et al.
  Udgivet: (2011)
• A Promising Therapeutic Approach for Multiple Sclerosis: Recombinant T-Cell Receptor Ligands Modulate Experimental Autoimmune Encephalomyelitis by Reducing Interleukin-17 Production and Inhibiting Migration of Encephalitogenic Cells into the CNS
  af: Sinha, Sushmita, et al.
  Udgivet: (2007)
• Recombinant T Cell Receptor Ligand (RTL) Treats Experimental Stroke
  af: Subramanian, Sandhya, et al.
  Udgivet: (2009)
• GILT REQUIRED FOR RTL550-CYS-MOG TO TREAT EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS
  af: Burrows, Gregory G., et al.
  Udgivet: (2012)